Autologous transplantation of lung progenitor cells comes into reality for bronchiectasis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39566465.
- Also identified by DOI 10.1016/j.xcrm.2024.101821 and PMC identifier 11604412.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stem and progenitor cell-based regenerative therapies have the potential to cure chronic respiratory diseases. Yan et al.<sup>1</sup> reported a clinical trial of autologous P63<sup>+</sup> progenitor cell transplantation in bronchiectasis patients, highlighting autologous transplantation of P63<sup>+</sup> progenitor cells as a novel candidate therapeutic option to improve pulmonary gas exchange function and quality of life.
Medical subject headings
- Bronchiectasis
- Transplantation, Autologous
- Stem Cell Transplantation
- Lung
- Stem Cells